LIGAND PHARMACEUTICALS INCORPORATED Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $154.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2014-12-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2014-12-12
- LIGAND PHARMACEUTICALS INCORPORATED proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2014 was $154.00K, a 0.00% change from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2013 was $154.00K, a 24.19% increase from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2012 was $124.00K.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2011 was $0.00.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|
| 2014-12-31 | $154.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | $154.00K 10-K/A · filed 2014-12-12 |
| 2012-12-31 | $124.00K 10-K/A · filed 2014-12-12 |
| 2011-12-31 | $0.00 10-K/A · filed 2014-12-12 |
| 2010-12-31 | $0.00 10-K · filed 2013-03-14 |